S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)

What Went Wrong With Draft Kings Stock Price? 

Tuesday, December 7, 2021 | Thomas Hughes
What Went Wrong With Draft Kings Stock Price? 

A Perfect Storm Blows Draft Kings Off Course

While the underlying investment in Draft Kings (NASDAQ: DKNG) remains sound there are a number of headwinds holding back share prices. The headwinds start with the stock’s valuation and end with short-seller Jim Chanos. In between are a number of issues that have combined to make a perfect storm for this stock. The key takeaway is that, if you’re in this for the long-term and Draftkings was attractive at $50 it should be even more attractive at $30. In the end, this company is growing at a hyper-growth pace with multiple positive catalysts lurking in the shadows. 

Short-Sellers Take A Bite Out Of Draft Kings 

The short-interest on Draft Kings has been running high all year and is sitting above 11% now. This is due to the company’s high valuation relative to revenue and the expectation for profitability. Short-seller Jim Chanos underscored this point early in December when he revealed he’d been short all year. His reason is simple, he thinks the business model is flawed and will never prove profitable even in the most aggressive growth scenarios. 

"You can believe in sports betting, you can bet on football and basketball to your heart's content, but this business model is flawed," he asserted.

Aiding the sentiment are a number of events that may keep share prices down in the near to mid-term. To start, the company has been working to get back into the Las Vegas gambling scene. The company had to exit Las Vegas when Nevada ruled online gambling had to be regulated. A recent report revealed the Nevada license application has been sitting on someone’s desk since 2020 which doesn’t bode well for its acceptance. A similar application put in by competitor Fanduel has been pending since March of 2021. 

Compounding this issue is a ruling Florida that will stymie growth in that arena. A Federal court ruled in favor of parimutuel operators that a compact between Florida and the Seminole tribe should be vacated. The specific sticking point was a plan to allow Florida residents to gamble using tribal servers from outside tribal lands, a plan that would effectively shut the parimutuel operators out. 

And Then There Is Omicron … 

To make matters worse, there is the Omicron variant of COVID-19 to worry about. The rise of Omicron has cast a shadow of doubt on sports and sporting events. While the rise of the original strain spurred growth in some areas it curbed it in others and there is doubt things will happen the same way this time around. It is assumed those interested in online gaming are already doing so if they can and that any impact from Omicron will be negative. The end result is that revenue projections and the forecast for profitability are in question as well. 

The Technical Outlook: Draft Kings Might Be Bottoming 

Shares of Draft Kings might be bottoming and here’s why. With shares down more than 40% from the recent highs they are presenting an attractive exit for short-sellers and there is still a very positive vibe for this stock on Wall Street. The Marketbeat.com consensus of 27 analysts is a Buy with a price target more than 100% above the current price action. In that light, shares may move lower in the nearer term but, without some change in actual sentiment, it will only coil the spring tighter and make the rebound that much stronger. Draft Kings will next report earnings at the end of February. 

What Went Wrong With Draft Kings Stock Price? 

Should you invest $1,000 in DraftKings right now?

Before you consider DraftKings, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DraftKings wasn't on the list.

While DraftKings currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
DraftKings (DKNG)3.0$19.46-5.9%N/A-5.30Buy$58.33
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]etbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.